Subscribe

What are you looking for?

Main Menu

明報新聞網

微創醫療：NEJM發表循證醫學結果 股價曾升逾7%

Future Wealths
Future Wealths
1 9 月, 2025
One Min Read
5 Views
0 Comments
微創醫療(0853)公布，《新英格蘭醫學雜誌》與歐洲心臟病學大會同步發表循證醫學結果，證實植入Firehawk®╱火鷹®支架低風險心肌梗死患者實際僅需1個月雙抗療程且出血併發症減少54%。

原文: https://finance.mingpao.com/fin/instantf/20250901/1756693804816/%e5%be%ae%e5%89%b5%e9%86%ab%e7%99%82-nejm%e7%99%bc%e8%a1%a8%e5%be%aa%e8%ad%89%e9%86%ab%e5%ad%b8%e7%b5%90%e6%9e%9c-%e8%82%a1%e5%83%b9%e6%9b%be%e5%8d%87%e9%80%be7

Last Update: 1 9 月, 2025

Please share this article if you like it!

Link Copied!
Future Wealths
Written By

Future Wealths

Other Articles

Related Posts

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept